Skip to main content

User account menu

  • Log in
  • Register
  • Contact
BandwidthHigh

Language switcher

  • English
  • Français
  • Español

Main navigation

    • About us
    • Our work
    • Rationale
    • IDDO Team
    • Contact us
    • Our partners
    • Governance
    • IDDO Board
    • Data Access Committee
    • Data reuse
    • Contributing data
    • Accessing data
    • IDDO legal and regulatory documentation
    • IDDO data sharing registrations
    • Data Access Guidelines
    • Frequently Asked Questions
    • Research themes
    • WWARN - malaria
    • COVID-19
    • Ebola
    • Visceral leishmaniasis
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
    • Research
    • Malaria Tracking Resistance
    • Malaria Clinical Trials Toolkit
    • COVID-19 LSR Tool
    • VL Tool
    • Medicine Quality Monitoring Globe
    • Medicine Quality Scientific Literature Surveyor
    • Febrile Illness Surveyor
    • Publications
    • Tools & resources
    • Medical Product Quality Reports
  • News
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation

WWARN News

Please visit WWARN's website for regular updates on malaria and sign up for the WWARN newsletter here. 

Credit: Pearl Gan
Thursday, 29 January 2015

TRAC study samples to be made available to the malaria research community

Thursday, 29 January 2015

Responding to regional challenges in Africa

Thursday, 22 January 2015

Grant Dorsey, University of California

Thursday, 22 January 2015

Genetic architecture of resistance

Study identifies 26 independent mutations on the kelch 13 gene, from 15 different locations in Southeast Asia, were associated with a delayed rate of malaria parasite clearance – a clear indicator of malaria drug resistance.
Tuesday, 9 December 2014

WHO releases World Malaria Report 2014

Monday, 8 December 2014

Spread of antimalarial molecular resistance to sulphadoxine-pyrimethamine

Monday, 8 December 2014

Antimalarial Drug Treatment Policy Developments in Africa

Monday, 8 December 2014

Philippe Guérin Suggests Data Management Could Support Antibiotic Resistance Research

Monday, 8 December 2014

New Genome Sequencing Technologies Detect Populations of Malaria-Resistant Parasites

Monday, 8 December 2014

Candidate Markers of Delayed P. Falciparum Clearance After Artemisinin Treatment

Thursday, 4 December 2014

WWARN appeals for worldwide cooperation to beat spread of antimalarial resistance

Thursday, 4 December 2014

WWARN launched with BMGF grant

Thursday, 27 November 2014

Antimalarial drug resistance: at what cost?

Sunday, 22 July 2012

An interview with Arjen Dondorp

Thursday, 19 January 2012

WWARN and Sanofi agree data sharing collaboration

Tuesday, 22 November 2011

Awa Marie Coll-Seck, RBM

Saturday, 22 October 2011

WWARN Director Philippe Guérin

Saturday, 22 October 2011

Robert Newman, Former Director, Global Malaria Programme, World Health Organization

Friday, 7 October 2011

Francine Ntoumi, CANTAM

Tuesday, 24 June 2008

Study demonstrates mass drug administration effective at supporting malaria elimination in remote ‘hotspots’ of Myanmar

A study recently published in The Lancet suggests that early diagnosis and treatment combined with mass drug administration significantly decreased P. falciparum incidence in certain malaria hotspot areas of Eastern Myanmar

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • Current page 38

Sign up for the IDDO newsletter

Sign up for the WWARN newsletter
linkedin [#161] Created with Sketch. youtube

Footer menu

  • Cookies
  • Privacy Notice
  • Accessibility
  • Sitemap
  • Terms of use
© 2025 Infectious Diseases Data Observatory